From 5,000 to 10,000 to one million and beyond. The scale of so-called genome-wide association studies (GWAS) has grown at a voracious pace over the last decade. And there’s no sign the initiatives are slowing down. As sequencing and data analysis costs continue to drop, public and private teams will likely push forward with even more ambitious projects.
